Investors / United States / MBX Capital
MBX Capital
Venture capital · Tuxedo Park, NY, United States · North America
MBX Capital is an early-stage life sciences venture capital firm. It backs companies in the area it calls Deep Health.
Invests inHealthcare & Biotech
In its own wordslife scienceshealthcarebiotechdeep health
Your fit with MBX Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsMBX Capital lists 27 checked portfolio companies on its own site and is named in 2 funding rounds. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (87%), AI & Machine Learning (10%) and Consumer (3%). 87% of its companies are based in United States. It invests most often alongside Y Combinator, Metaplanet and Amboy Street Ventures.
Counts come from funding rounds that name MBX Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not MBX Capital's whole history. Rounds on record name 2 companies; its own site lists 27. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 100% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 64th | 27 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 59th | 4% of companies confirmed by a round |
| Sector focus | 95th | 87% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Y Combinator | 4 |
| Metaplanet | 3 |
| Amboy Street Ventures | 2 |
| Axial | 2 |
| Beni VC | 2 |
| Creative Destruction Lab | 2 |
| Draper Associates | 2 |
| Fifty Years | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers27100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 87% | 15% |
| AI & Machine Learning | 10% | 18% |
| Consumer | 3% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare MBX Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with MBX Capital| Date | Company | Stage |
|---|---|---|
| 15 Apr 2026 | Series A | |
| 1 Jan 2026 | Series A |
Round details for MBX Capital
Amounts, full round histories and every co-investor in MBX Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
27 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AmacaThera develops a hydrogel drug delivery platform for precise and sustained release of therapeutics | Healthcare & Biotech | Portfolio page | ||
| The company harnesses the natural power of CRISPR to tackle the virome and develop novel therapies | Healthcare & Biotech | Portfolio page | ||
| Arine provides comprehensive medication management solutions to improve health outcomes through medication optimization | Healthcare & Biotech | Portfolio page | ||
| Atlas Health matches and enrolls patients into funding sources to increase coverage and reimbursement while improving patient access and clinical outcomes. | Healthcare & Biotech | Portfolio page | ||
| Attivare Therapeutics develops personalized cancer immunotherapy treatments using artificial intelligence and biomaterials | Healthcare & Biotech | Portfolio page | ||
| Case45 develops zero-shot AI for oncology. | Healthcare & Biotech | Portfolio page | ||
| Catena Biosciences develops therapeutic structures, including antibody-drug conjugates, using its CysTyr Conjugation Platform. | Healthcare & Biotech | Portfolio page | ||
| CND Life Sciences develops and provides diagnostic tests, including the Syn-One Test, to help diagnose neurological conditions such as Parkinson's disease | Healthcare & Biotech | Portfolio page | ||
| Contraline is a company developing investigational male contraceptive products, including a topical gel and a reversible implant. | Healthcare & Biotech | Portfolio page | ||
| Current Surgical is a company that develops and applies a new focused ultrasound technology stack to reinvent surgery for the modern era. | Healthcare & Biotech | Portfolio page | ||
| Dognosis combines the olfactory capabilities of dogs with advanced technology to detect diseases such as cancer | Healthcare & Biotech | Portfolio page | ||
| Earli uses AI to build genetic switches that program only cancer cells to make their own therapies | Healthcare & Biotech | Portfolio page | ||
| Eden builds the infrastructure and frontier AI that turn diagnostic data into precise clinical answers. | Healthcare & Biotech | Portfolio page | ||
| Examol provides computational drug discovery solutions | Healthcare & Biotech | Portfolio page | ||
| Freedom Biosciences is a biotechnology platform developing next-generation neuropsychiatric therapeutics. | Healthcare & Biotech | Portfolio page | ||
| Junction Health partners with Community Health Centers to improve access to care and thrive financially by building and operating on-site infusion centers | Healthcare & Biotech | Portfolio page | ||
| Juniper Genomics helps clinicians and patients access deeper genomic insight for fertility treatment decisions | Healthcare & Biotech | Portfolio page | ||
| Keebler Health processes patient records and provides risk insights to clinicians using AI-driven clinical analysis | Healthcare & Biotech | Apr 2026Series A | Funding round | |
| Lucy Goods Inc produces and sells nicotine products, including pouches, gum, and other tobacco-free items. | Healthcare & BiotechConsumer | Portfolio page | ||
| The company designs and provides lab automation products and services, including workstations, modules, and software. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- mbxcapital.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 1 Jan 2026
- Companies checked
- 27
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get MBX Capital's profile as data
Pull MBX Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/mbxcapital.com
# also
GET /v1/firms/mbxcapital.com/portfolio
GET /v1/firms/mbxcapital.com/coinvestors
GET /v1/firms/mbxcapital.com/news